Tesla’s Autopilot Draws Regulatory Scrutiny, Volkswagen Expects Supply Crisis To Continue, TikTok To Launch Standalone Gaming Channel: Top Stories Friday, Oct. 28
Wall Street Journal
Tesla's Autopilot Draws Regulatory Ire From DoJ and SEC
AbbVie Reports Mixed Earnings, Tightens Guidance, Lifts Quarterly Dividend
AbbVie Inc (NYSE:ABBV) reported Q3 adjusted EPS of $3.66, up 29.3% Y/Y and beating the consensus of $3.59. Overall sales…
AbbVie Q3 EPS $3.66 Beats $3.59 Estimate, Sales $14.81B Miss $14.96B Estimate
AbbVie (NYSE:ABBV) reported quarterly earnings of $3.66 per share which beat the analyst consensus estimate of $3.59 by 1.95 percent. This is a 29.33 percent increase over earnings of $2.83 per share from the same period
Analyzing AbbVie’s Short Interest
AbbVie's (NYSE:ABBV) short percent of float has risen 5.33% since its last report. The company recently reported that it has 14.00 million shares sold short, which is 0.79% of all regular shares that are available for trading.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Alpine Immune Sciences Stops Davoceticept Trials In Cancer Indications After Second Patient Death
Alpine Immune Sciences Inc (NASDAQ:ALPN) has voluntarily terminated enrollment in both clinical studies involving davoceticept (ALPN-202), an investigational CD28 costimulator, and…
AbbVie Announces RINVOQ (Upadacitinib) Receives Sixth U.S. FDA Approval
AbbVie (NYSE:ABBV) today announces that the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib 15 mg, once daily), an oral therapy, for the treatment of adults with active
SVB Leerink Maintains Underperform on AbbVie, Lowers Price Target to $135
SVB Leerink analyst David Risinger maintains AbbVie (NYSE:ABBV) with a Underperform and lowers the price target from $140 to $135.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Check Out What Whales Are Doing With ABBV
Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.